药明康德：与全球前20大制药企业全部建立合作伙伴关系

Core Insights - WuXi AppTec (603259.SH/2359.HK) disclosed at the 44th JPMorgan Healthcare Conference that it has served over 9,000 preclinical clients from 2011 to 2025 [1] - The company has established long-term stable partnerships with all of the top 20 global pharmaceutical companies [1] - WuXi AppTec operates a global network of over 20 R&D and manufacturing bases across Asia, Europe, and North America [1] Infrastructure and Capacity - The company has GLP laboratory space exceeding 120,000 square meters [1] - The total volume of small molecule active pharmaceutical ingredient reactors exceeds 4 million liters [1] - The total volume of peptide solid-phase synthesis reactors has surpassed 100,000 liters [1]